Colorectal Cancer Screening Guideline Update – May 30, 2018
On May 30, 2018, the American Cancer Society released a new colorectal cancer screening guideline, published in CA: A Cancer Journal for Clinicians. The new guideline recommends that adults at average risk for colorectal cancer start regular screening at age 45. The guideline was changed, based in part, on new data showing rates of colorectal cancer are increasing in younger populations. As a result, the American Cancer Society updated the guideline to save more lives by finding colorectal cancer early, when treatment is more likely to be successful and by detecting and removing polyps, which contributes to the prevention of colorectal cancer.
This webinar assists NCCRT members and 80% partners by answering common questions, reviewing the evidence-base behind the guideline, and discussing how it will apply in a clinical setting.
Speakers:
- Rich Wender, MD, Chief Cancer Control Officer, ACS, National Colorectal Cancer Roundtable (NCCRT) Chair
- Robert Smith, PhD, VP, Cancer Screening, ACS, NCCRT Co-Chair
- Durado Brooks, MD, MPH, VP of Cancer Control Interventions, NCCRT Steering Committee/Co-Chair Community Health Center Task Group
- Caroline Powers, Federal Affairs Director, ACS CAN
Additional Resources:
- Video message from Dr. Richard Wender
- Issue Brief and FAQ for NCCRT Members and 80% Pledger Signers
- ACS Press Release
Explore More

Blue Star Conversation: July 9, 2025
This Blue Star Conversation covered the topic, "2025 Supreme Court Case Update: How Kennedy v. Braidwood Management Could Affect Insurance Coverage for CRC Screening".

Blue Star Conversation: April 15, 2025
This Blue Star Conversation covered, "Modeling the Impact of Colorectal Cancer Screening and Timely Follow-Up Colonoscopy: Recent Data from the Cancer Intervention and Surveillance Modeling Network (CISNET)"

Clinician’s Reference: Stool-Based Tests for Colorectal Cancer Screening
This revised resource is designed to introduce (or reintroduce) clinicians to the value of stool-based testing for colorectal cancer.